BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shang T, Guo Y, Li X, Zhou Z, Qi Y, Salahdiin K, Shen R, He S, Wang M, Shi Z, Zhao X, Yang J, Fan G, Wang Y, Gao X, Zhu Y, Feng Y. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment. Biomedicine & Pharmacotherapy 2022;148:112675. [DOI: 10.1016/j.biopha.2022.112675] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Wei L, Zhang L, Zhang Y, Yan L, Liu B, Cao Z, Zhao N, He X, Li L, Lu C. Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases. J Ethnopharmacol 2023;:116381. [PMID: 36940735 DOI: 10.1016/j.jep.2023.116381] [Reference Citation Analysis]
2 Zhou J, Zhang R, Guo P, Li P, Huang X, Wei Y, Yang C, Zhou J, Yang T, Liu Y, Shi S. Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1032290] [Reference Citation Analysis]
3 Shang T, Zhang Z, Wang X, Chang J, Zhou M, Lyu M, He S, Yang J, Chang Y, Wang Y, Li M, Gao X, Zhu Y, Feng Y. Xuebijing injection inhibited neutrophil extracellular traps to reverse lung injury in sepsis mice via reducing Gasdermin D. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1054176] [Reference Citation Analysis]